NextCure, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 62.72 million compared to USD 74.73 million a year ago. Basic loss per share from continuing operations was USD 2.25 compared to USD 2.69 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.66 USD | +5.06% | +11.07% | +45.18% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+45.18% | 44.2M | |
+2.47% | 108B | |
+9.65% | 105B | |
+1.57% | 23.46B | |
-12.66% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.89% | 17.19B | |
+6.00% | 13.99B | |
+34.93% | 12.53B |
- Stock Market
- Equities
- NXTC Stock
- News NextCure, Inc.
- NextCure, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023